Results 291 to 295 of about 948,853 (295)
Some of the next articles are maybe not open access.

Targeting the IL-6/JAK/STAT3 signalling axis in cancer

Nature Reviews Clinical Oncology, 2018
Daniel E Johnson, Jennifer R Grandis
exaly  

[TF (tissue factor), TFPI (tissue factor pathway inhibitor)].

Nihon rinsho. Japanese journal of clinical medicine, 2005
Yoshitaka, Mori, Hideo, Wada
openaire   +1 more source

DNA double-strand break repair-pathway choice in somatic mammalian cells

Nature Reviews Molecular Cell Biology, 2019
Ralph Scully   +2 more
exaly  

The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy

Nature Reviews Cancer, 2019
Jonathan J Havel   +2 more
exaly  

The evolving landscape of tissue‐agnostic therapies in precision oncology

Ca-A Cancer Journal for Clinicians
Vivek Subbiah   +2 more
exaly  

Home - About - Disclaimer - Privacy